FTO and breast carcinoma: In addition, among the above-mentioned FTO inhibitors, Rhein and MO-I-500 have been reported to significantly inhibit the growth ability of breast cancer cells in vivo and in vitro (Singh et al., 2016; Niu et al., 2019).